Catalyst Wire Dossier Catalyst Wire Dossier

Potassium Canrenoate

potassium canrenoate
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Potassium Canrenoate, covering 2018-05-25 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial [Phase 2]

See pricing